Some of the infectious ailments spread by mosquitoes such as yellow fever, Zika, Chikungunya, and dengue are growing concerns in the U.S. and globally. To successfully combat these diseases, you will have to deal with their vectors effectively. Recently, permission was granted to the piloting program in Florida to release genetically modified mosquitoes to the environment. The initiative is to help combat the spread of these infectious diseases.
The proponent of this project is Oxitec which aims at controlling and combating insect pests such as the medflies, mosquitoes, and diamondback moths. The project has been fully supported by the Florida Keys Mosquito Control District Board of Commissioners (“FKMCD”). The project is now going to be brought to reality after...
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.